Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yongming Qu, Mayme Wong, Daniel Thiebaud & John L. Stock. (2005) The effect of raloxifene therapy on the risk of new clinical vertebral fractures at three and six months: a secondary analysis of the MORE trial. Current Medical Research and Opinion 21:12, pages 1955-1959.
Read now
Read now
Articles from other publishers (14)
Edmund Charles Jenkins, Mrittika Chattopadhyay & Doris Germain. (2021) Folding Mitochondrial-Mediated Cytosolic Proteostasis Into the Mitochondrial Unfolded Protein Response. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Li-Ping Zhou, Ka-Ying Wong, Hoi-Ting Yeung, Xiao-Li Dong, Hui-Hui Xiao, Amy G.-W. Gong, Karl W.-K. Tsim & Man-Sau Wong. (2018) Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro. Frontiers in Pharmacology 9.
Crossref
Crossref
Javier Labad, Lourdes Martorell, Elena Huerta-Ramos, Jesús Cobo, Elisabet Vilella, Elena Rubio-Abadal, Gemma Garcia-Pares, Marta Creus, Cristian Núñez, Laura Ortega, Eva Miquel & Judith Usall. (2016) Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial. European Neuropsychopharmacology 26:10, pages 1683-1689.
Crossref
Crossref
Judith Usall, Elena Huerta-Ramos, Javier Labad, Jesús Cobo, Christian Núñez, Marta Creus, Gemma García Parés, Daniel Cuadras, José Franco, Eva Miquel, Julio César Reyes & Mercedes Roca. (2016) Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial. Schizophrenia Bulletin 42:2, pages 309-317.
Crossref
Crossref
Atul Kumar, Vishwa Deepak Tripathi, Promod Kumar, Lalit Prakash Gupta, Akanksha, Ritu Trivedi, Hemant Bid, V.L. Nayak, Jawed A. Siddiqui, Bandana Chakravarti, Ruchi Saxena, Anila Dwivedi, M.I. Siddiquee, U. Siddiqui, Rituraj Konwar & Naibedya Chattopadhyay. (2011) Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents. Bioorganic & Medicinal Chemistry 19:18, pages 5409-5419.
Crossref
Crossref
Yukako Tabuchi, Yuko Ando, Hidemi Kanemura, Ikuo Kawasaki, Takahiro Ohishi, Masao Koida, Ryo Fukuyama, Hiromichi Nakamuta, Shunsaku Ohta, Kiyoharu Nishide & Yoshitaka Ohishi. (2009) Preparation of novel (Z)-4-ylidenebenzo[b]furo[3,2-d][1,3]oxazines and their biological activity. Bioorganic & Medicinal Chemistry 17:11, pages 3959-3967.
Crossref
Crossref
Yonghua Wang, Yan Li, Jun Ding, Yuan Wang & Yaqing Chang. (2008) Prediction of binding affinity for estrogen receptor α modulators using statistical learning approaches. Molecular Diversity 12:2, pages 93-102.
Crossref
Crossref
Kevin D. Dykstra, Liangqin Guo, Elizabeth T. Birzin, Wanda Chan, Yi Tien Yang, Edward C. Hayes, Carolyn A. DaSilva, Lee-Yuh Pai, Ralph T. Mosley, Bryan Kraker, Paula M.D. Fitzgerald, Frank DiNinno, Susan P. Rohrer, James M. Schaeffer & Milton L. Hammond. (2007) Estrogen receptor ligands. Part 16: 2-Aryl indoles as highly subtype selective ligands for ERα. Bioorganic & Medicinal Chemistry Letters 17:8, pages 2322-2328.
Crossref
Crossref
Ana Paula V. Dantas & Kathryn Sandberg. (2005) Challenges and opportunities associated with targeting estrogen receptors in treating hypertension and cardiovascular disease. Drug Discovery Today: Therapeutic Strategies 2:3, pages 245-251.
Crossref
Crossref
Philippe Orcel. (2005) Ostéoporose post-ménopausique : traiter aujourd'hui et demain. Revue du Rhumatisme 72, pages S10-S15.
Crossref
Crossref
Subhendu Mukherjee, Achintya Saha & Kunal Roy. (2005) QSAR of estrogen receptor modulators: exploring selectivity requirements for ERα versus ERβ binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters. Bioorganic & Medicinal Chemistry Letters 15:4, pages 957-961.
Crossref
Crossref
P Cozzini & T Dottorini. (2004) Is it possible docking and scoring new ligands with few experimental data? Preliminary results on estrogen receptor as a case study. European Journal of Medicinal Chemistry 39:7, pages 601-609.
Crossref
Crossref
Jinn-Moon Yang & Tsai-Wen Shen. (2004) A pharmacophore-based evolutionary approach for screening estrogen receptor antagonists. A pharmacophore-based evolutionary approach for screening estrogen receptor antagonists.
George D. Hartman & Robert S. Meissner. 2004.
67
78
.